CN101305798A - Cailv capsules - Google Patents

Cailv capsules Download PDF

Info

Publication number
CN101305798A
CN101305798A CNA2007100777621A CN200710077762A CN101305798A CN 101305798 A CN101305798 A CN 101305798A CN A2007100777621 A CNA2007100777621 A CN A2007100777621A CN 200710077762 A CN200710077762 A CN 200710077762A CN 101305798 A CN101305798 A CN 101305798A
Authority
CN
China
Prior art keywords
parts
capsule
oil
cailv
pill
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007100777621A
Other languages
Chinese (zh)
Inventor
唐晨光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2007100777621A priority Critical patent/CN101305798A/en
Publication of CN101305798A publication Critical patent/CN101305798A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a CAILV capsule, which belongs to the field of food. The preparation of the capsule comprises mixing 2 to 4 parts of gamma-linolenic acid, 10 to 12 parts of Houttuyniae oil and 50 to 60 parts of VE uniformly according to the weight parts to obtain an oil material for later use; preparing a gelatin material by the conventional method; and making the oil material and the gelatin material into seamless gelatin pill, drying, cleaning, and drying to obtain the hardened gelatin pill. The capsule has the effects of promoting gastrointestinal absorption, effectively protecting lung cells, preventing and treating hyperlipidemia and cerebral hemorrhage, inhibiting oxidization of cells, resisting aging and protecting health.

Description

Cailv capsules
Technical field
The present invention relates to field of food, relate in particular to a kind of Cailv capsules, also relate to its production method simultaneously.
Background technology
The r-leukotrienes is to keep the necessary aliphatic acid of the normal biological function of human body, and it is synthetic that it participates in several physiology of a series of metabolism of human body directly, in immune system, cardiovascular system, reproductive system, internal system the important physical effect arranged all.As prostatic precursor substance, it can promote trans-utilizations such as cholesterol, participate in the chemical synthesis of cell directly, regulate the biochemical movable of cell, at reducing blood lipid, norcholesterol, prevent to have good result aspect atherosclerotic, hypoglycemic, fat-reducing, the beauty treatment.These type of health products are more at present, but the linolenic content of r-is lower usually, DeGrain.
Herba Houttuyniae oil, mainly the decanoy acetaldehyde that refines in lard oil and the base of leaf from the cordate houttuynia seed is clearing heat and detoxicating, inducing diuresis to reduce edema.Control pneumonia, lung abscess, hot dysentery, malaria, oedema, gonorrhoea, leukorrhea, carbuncle is swollen, hemorrhoid, prolapse of the anus, eczema, the favus of the scalp, mange.
Summary of the invention
The objective of the invention is to overcome above-mentioned shortcoming and a kind of energy accelerate gastrointestinal absorption is provided, protect lung cells effectively, prevention and treatment high fat of blood, cerebral hemorrhage have the inhibition cellular oxidation, the Cailv capsules of the effect of anti-ageing healthcare.
Another object of the present invention is to provide the production method of this Cailv capsules.
A kind of Cailv capsules of the present invention is made by the raw material of following weight parts:
R-leukotrienes 50-60 part Herba Houttuyniae oil 10-12 part VE2-4 part.
Preferred weight part is:
11 parts of VE3 parts of 55 parts of Herba Houttuyniae oils of r-leukotrienes.
The production method of Cailv capsules of the present invention comprises the steps:
(1) r-leukotrienes, Herba Houttuyniae oil and VE are mixed by said ratio, it is standby to get oil plant;
(2) produce sizing material according to a conventional method, standby;
(3) oil plant and sizing material are made seamless capsule and pill by the soft capsule maker, and drying, cleaning finally are dried to after the capsule and pill hardening promptly.
The present invention compared with prior art, by such scheme as can be known, all raw materials are the pure natural raw material, do not add any chemical addition agent, thereby are a kind of pollution-free foods of edible safety.Through experimental results show that component of the present invention and proportioning repeatedly, the energy accelerate gastrointestinal absorption is protected lung cells effectively, and prevention and treatment high fat of blood, cerebral hemorrhage have the inhibition cellular oxidation, the effect of anti-ageing healthcare.
The specific embodiment
Embodiment 1
(1) r-leukotrienes 55g, Herba Houttuyniae oil 11g and VE3g are mixed, it is standby to get oil plant;
(2) produce sizing material according to a conventional method, be about to water and glycerine, be heated to 70-80 ℃, slowly drop into gelatin after stirring, vigorous stirring continues to be heated to 90-100 ℃ simultaneously, is incubated after 3-4 hour, filters while hot, is cooled to 60-65 ℃, and it is standby to get sizing material;
(3) oil plant and sizing material are made seamless capsule and pill by the soft capsule maker, and drying, cleaning finally are dried to after the capsule and pill hardening promptly.
Embodiment 2
(1) r-leukotrienes 50g, Herba Houttuyniae oil 10g and VE2g are mixed, it is standby to get oil plant;
(2) produce sizing material according to a conventional method, be about to water and glycerine, be heated to 70-80 ℃, slowly drop into gelatin after stirring, vigorous stirring continues to be heated to 90-100 ℃ simultaneously, is incubated after 3-4 hour, filters while hot, is cooled to 60-65 ℃, and it is standby to get sizing material;
(3) oil plant and sizing material are made seamless capsule and pill by the soft capsule maker, and drying, cleaning finally are dried to after the capsule and pill hardening promptly.
Embodiment 3
(1) r-leukotrienes 60g, Herba Houttuyniae oil 12g and VE4g are mixed, it is standby to get oil plant;
(2) produce sizing material according to a conventional method, be about to water and glycerine, be heated to 70-80 ℃, slowly drop into gelatin after stirring, vigorous stirring continues to be heated to 90-100 ℃ simultaneously, is incubated after 3-4 hour, filters while hot, is cooled to 60-65 ℃, and it is standby to get sizing material;
(3) oil plant and sizing material are made seamless capsule and pill by the soft capsule maker, and drying, cleaning finally are dried to after the capsule and pill hardening promptly.

Claims (3)

1, a kind of Cailv capsules is made by the raw material of following weight parts:
R-leukotrienes 50-60 part Herba Houttuyniae oil 10-12 part VE2-4 part.
2, Cailv capsules as claimed in claim 1 is made by the raw material of following weight parts: 11 parts of VE3 parts of 55 parts of Herba Houttuyniae oils of r-leukotrienes.
3, the production method of Cailv capsules as claimed in claim 1 or 2 comprises the steps:
(1) r-leukotrienes, Herba Houttuyniae oil and VE are mixed by said ratio, it is standby to get oil plant;
(2) produce sizing material according to a conventional method, standby;
(3) oil plant and sizing material are made seamless capsule and pill by the soft capsule maker, and drying, cleaning finally are dried to after the capsule and pill hardening promptly.
CNA2007100777621A 2007-05-15 2007-05-15 Cailv capsules Pending CN101305798A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007100777621A CN101305798A (en) 2007-05-15 2007-05-15 Cailv capsules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007100777621A CN101305798A (en) 2007-05-15 2007-05-15 Cailv capsules

Publications (1)

Publication Number Publication Date
CN101305798A true CN101305798A (en) 2008-11-19

Family

ID=40122667

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007100777621A Pending CN101305798A (en) 2007-05-15 2007-05-15 Cailv capsules

Country Status (1)

Country Link
CN (1) CN101305798A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181971A (en) * 2011-12-30 2013-07-03 新昌县冠阳技术开发有限公司 Heartleaf houttuynia herb oil enteric-coated capsules

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239511A (en) * 1985-08-13 1987-02-20 Kanebo Ltd Cosmetic for preventing aging of skin
CN1355038A (en) * 2000-12-01 2002-06-26 王锁春 Health-care product prepared from arnebia seed and its preparing process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239511A (en) * 1985-08-13 1987-02-20 Kanebo Ltd Cosmetic for preventing aging of skin
CN1355038A (en) * 2000-12-01 2002-06-26 王锁春 Health-care product prepared from arnebia seed and its preparing process

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"维生素E与身体健康", 《中国保健营养》 *
俞志成: "鱼腥草的药用价值与人工栽培", 《专业户》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181971A (en) * 2011-12-30 2013-07-03 新昌县冠阳技术开发有限公司 Heartleaf houttuynia herb oil enteric-coated capsules

Similar Documents

Publication Publication Date Title
CN106591386A (en) Preparation method of composition containing 2-tripalmitin
CN1969833A (en) Dry powder composition containing CoQ10 and preparation process thereof
CN101434639B (en) Green technological process for preparing sterol fatty acid ester
CN107828830A (en) A kind of method that backbone triglycerides forms in adjustment
CN102742844A (en) Ready-to-eat health-care linseed powder and preparation method thereof
CN102696783A (en) Walnut oil and processing method thereof
CN104522188A (en) Powdered oil rich in medium and low carbonic acid and preparation method thereof
CN103766737A (en) Whole-grain nutritious food
CN103478522A (en) Donkey-hide gelatin and propolis soft capsules and preparation method thereof
CN107581615A (en) Special diet containing Structure grease
CN101305798A (en) Cailv capsules
CN106867856A (en) A kind of linseed oil health-care vinegar and preparation method thereof
CN101731562A (en) Salt containing carotene and iodine and processing method thereof
CN106367199A (en) Preparing process for millet oil
CN101768531A (en) Preparation method of natural soap
CN101084925B (en) Technology for producing pilose antler mother solution
CN102277237A (en) Preparation method of high-purity glyceride type fish oil
CN102630762A (en) Production method for spreading type cream
CN105638934B (en) A kind of ginkgo composite edible oil
Chávez et al. Valuation strategies for the biomass generated while producing and transforming cocoa into chocolate
CN101530227A (en) Houttuynia cordata thunb rosa roxburghii tratt. beverage
CN103393844A (en) Medicament formula for treating stomach illness
CN102511825B (en) Functional health microcapsule of turtle oil and for blood fat reduction and preparation method thereof
CN105838500A (en) Microwave-assisted supercritical carbon dioxide extraction method for okra seed oil
CN109430847A (en) A kind of tea oil soft capsule and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20081119